Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
TACHOSIL human fibrinogen 5.5mg/square cm and human thrombin 2.0IU/square cm medicated sponge blister pack, Takeda Pharmaceuticals Australia Pty Ltd, CON-285
Product name
TACHOSIL human fibrinogen 5.5mg/square cm and human thrombin 2.0IU/square cm medicated sponge blister pack
Sponsor name
Takeda Pharmaceuticals Australia Pty Ltd
Consent start
Consent no.
CON-285
Standard
Paragraphs 10(13)(a)(vi) and 10(13)(a)(vii) of Therapeutic Goods Order No. 91 - Standard for labels for prescription and related medicines.
Non-compliance with standard
The product's immediate blister pack labels do not include the names and
quantities of all active ingredients in the medicine.
Conditions imposed
The labels to which this consent applies are those previously approved to be
exempted from compliance with subclauses 3(12)(b) and 3(2)(b) and (c) of the
Therapeutic Goods Order No. 69 - General Requirements for Labels for Medicines.
Therapeutic product type
Prescription medicines